Masashi Miyaoka

Years Active: 2019-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Atsushi Ito, Masashi Miyaoka, Sakura Tomita, Haruka Ikoma, Shinichiro Hiraiwa, Joaquim Carreras, Yara Yukie Kikuti, Hiroshi Kawada, Naoya Nakamura
The multilobated morphology is still a better prognosis factor of diffuse large B-cell lymphoma in the R-CHOP era. Pathology international 72 (11) (2022)
Haruka Ikoma, Masashi Miyaoka, Shinichiro Hiraiwa, Yara Yukie Kikuti, Sawako Shiraiwa, Ryujiro Hara, Minoru Kojima, Ken Ohmachi, Kiyoshi Ando, Joaquim Carreras, Naoya Nakamura
Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements. Pathology international 72 (6) (2022)
Masashi Miyaoka, Yara Yukie Kikuti, Joaquim Carreras, Atsushi Itou, Haruka Ikoma, Sakura Tomita, Sawako Shiraiwa, Kiyoshi Ando, Naoya Nakamura
AID is a poor prognostic marker of high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. Pathology international (2021)
Kenichi Hirabayashi, Takuma Tajiri, Dustin E Bosch, Masashi Morimachi, Masashi Miyaoka, Chie Inomoto, Naoya Nakamura, Matthew M Yeh
Loss of nectin-3 expression as a marker of tumor aggressiveness in pancreatic neuroendocrine tumor. Pathology international 70 (2) (2019)

Masashi Miyaoka.css-eqlu8i{font-size:small;padding-left:4px;}